BCRX Trading Below Director's Recent Buy Price

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 24, BioCryst Pharmaceuticals Inc's Director, Vincent Milano, invested $91,425.00 into 7,500 shares of BCRX, for a cost per share of $12.19..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.